PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummarySep 24, 2001	Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook PLAINSBORO, N.J., Sep 24, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has scheduled a conference call for Tuesday, October 2, 2001 at 8:30 AM	View HTML Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook 10.4 KB
Toggle SummaryDec 23, 2013	Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Dec. 23, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has completed patient enrollment in a multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Integra ® Dermal Regeneration	View HTML Integra LifeSciences Announces Completion of Patient Enrollment in Clinical Study of Integra(R) Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers 13.2 KB
Toggle SummaryAug 5, 2014	Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has completed Its multicenter clinical trial evaluating the safety and effectiveness of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers	View HTML Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers 13.8 KB
Toggle SummaryJun 27, 2001	Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding	View HTML Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA 13 KB
Toggle SummaryOct 2, 2006	Integra LifeSciences Announces Completion of Exchange Offer for its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 Integra LifeSciences Announces Completion of Exchange Offer for its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Oct. 2, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it completed its offer to exchange up to	View HTML Integra LifeSciences Announces Completion of Exchange Offer for its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 10.9 KB
Toggle SummaryJun 28, 2023	Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study Achieves Significant Milestone on Pathway to PMA Approval for Two-Stage Breast Reconstruction PRINCETON, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, announced the completion of patient enrollment in the	View HTML PDF Version
Toggle SummaryMar 12, 2010	Integra LifeSciences Announces Commercial Launch of Paramount(R) Pedicle Screw (PS) System for Minimally Invasive Spine Surgery PLAINSBORO, N.J., March 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today the U.S. commercial launch of Integra Spine's Paramount® Pedicle Screw (PS) Fixation System for minimally invasive spine surgery. Previously, the Paramount® PS system was available to a select	View HTML Integra LifeSciences Announces Commercial Launch of Paramount(R) Pedicle Screw (PS) System for Minimally Invasive Spine Surgery 15.6 KB
Toggle SummaryMar 28, 2017	Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System PLAINSBORO, N.J., March 28, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced full commercial availability of its Cadence ® Total Ankle System, a new ankle prosthesis developed in partnership with four	View HTML Integra LifeSciences Announces Commercial Expansion of the Cadence® Total Ankle System 17.1 KB
Toggle SummaryApr 29, 2014	Integra LifeSciences Announces Chief Financial Officer Transition PLAINSBORO, N.J., April 29, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective May 2, 2014 it has appointed Glenn G. Coleman Corporate Vice President and Chief Financial Officer, reporting to Jack Henneman, who was appointed Corporate	View HTML Integra LifeSciences Announces Chief Financial Officer Transition 14.5 KB
Toggle SummarySep 2, 2014	Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business PLAINSBORO, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has made changes to the leadership of its Orthopedics and Tissue Technologies business. The new organization enables Integra to use its resources more efficiently in	View HTML Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business 12.1 KB